Indications
Therapeutic Asset Ratings
91,565
assets
·
7,904
sponsors
·
3,128
indications
Methodology v0.2
Filters
Highest Rated
Advanced Phase
Alphabetical
Recently Updated
Asset
Sponsor
Phase
Rating
Etoposide
Fallopian Tube Cancer
Brigham and Women's Hospital
P2
BB
(71)
Etoposide
Pancreatic Neoplasm
Jinling Hospital, China
P2
BB
(71)
Everolimus
Glioblastoma
Nationwide Children's Hospital
P2
BB
(71)
Fludarabine
Cancer
National Cancer Institute (NCI)
P2
BB
(71)
Fludarabine
Cervical Cancer
City of Hope Medical Center
P2
BB
(71)
Fludarabine
Colorectal Cancer
University of Pennsylvania
P2
BB
(71)
Fludarabine
Congenital Amegakaryocytic Thrombocytopenia
Fred Hutchinson Cancer Center
P2
BB
(71)
Fludarabine
Neoplasm
National Cancer Institute (NCI)
P2
BB
(71)
Fludeoxyglucose
Breast Cancer
Peking University Cancer Hospital & Institute
P2
BB
(71)
Fluorouracilum
Adenocarcinoma
University of Chicago
P2
BB
(71)
Fluorouracilum
Urinary Bladder Carcinoma
Arcus Biosciences, Inc.
P2
BB
(71)
Fluorouracilum
Digestive System Cancer
Alliance for Clinical Trials in Oncology
P2
BB
(71)
Fluorouracilum
Ovarian Cancer
Lipomedix Pharmaceuticals Inc.
P2
BB
(71)
Fluorouracilum
Renal Cell Carcinoma
Neonc Technologies, Inc.
P2
BB
(71)
Fluorouracilum
Cancer Of Unknown Primary Site
Alliance for Clinical Trials in Oncology
P2
BB
(71)
Guadecitabine
Myelodysplastic Syndrome
Groupe Francophone des Myelodysplasies
P2
BB
(71)
Immunoglobulin G4, Anti-(Human Programmed Cell Death Protein 1) (Human Monoclonal Regn2810 Heavy Chain), Disulfide With Human Monoclonal Regn2810 .Kappa.-Chain, Dimer
Head And Neck Cancer
Bolt Biotherapeutics, Inc.
P2
BB
(71)
Inotuzumab Ozogamicin
B-Cell Non-Hodgkin Lymphoma
Dana-Farber Cancer Institute
P2
BB
(71)
Irinotecan
Non-Small Cell Lung Carcinoma
Jiangsu Hansoh Pharmaceutical Co., Ltd.
P2
BB
(71)
Isocyclophosphamide
Follicular Lymphoma
David Bond, MD
P2
BB
(71)
Mogamulizumab
Adult T-Cell Leukemia/Lymphoma
Memorial Sloan Kettering Cancer Center
P2
BB
(71)
Motixafortide
Pancreatic Adenocarcinoma
Gulam Manji
P2
BB
(71)
Nadravaleucel
Acute Myeloid Leukemia
Federal Research Institute of Pediatric Hematology, Oncology and Immunology
P2
BB
(71)
Obinutuzumab
Richter Transformation
Christine Ryan
P2
BB
(71)
Oxaliplatin
Adenocarcinoma
University of Chicago
P2
BB
(71)
Showing 2451 to 2475 of 42,285 assets
Previous
Page 99 of 1692
Next